Nyxoah SANASDAQ:NYXH
- LAST PRICE8.3300
- TODAY'S CHANGE (%)-0.1500 (-1.7689%)
- Bid / Lots7.7500/ 1
- Ask / Lots9.3500/ 3
- Open / Previous Close8.2500 / 8.4800
- Day Range
- 52 Week Range
- Volume21,365
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NYXH |
|---|---|---|
| 09:34 ET | 1100 | 8.35 |
| 09:41 ET | 200 | 8.35 |
| 09:52 ET | 3420 | 8.4 |
| 11:06 ET | 300 | 8.86 |
| 11:08 ET | 800 | 8.55 |
| 11:26 ET | 177 | 8.5 |
| 11:40 ET | 2100 | 8.4601 |
| 11:42 ET | 148 | 8.6 |
| 11:45 ET | 300 | 8.44 |
| 11:47 ET | 1350 | 8.45 |
| 11:54 ET | 1325 | 8.4601 |
| 12:25 ET | 100 | 8.52 |
| 12:30 ET | 400 | 8.55 |
| 12:32 ET | 200 | 8.52 |
| 12:41 ET | 121 | 8.475 |
| 01:42 ET | 700 | 8.43 |
| 02:49 ET | 200 | 8.4 |
| 02:51 ET | 300 | 8.4 |
| 02:56 ET | 500 | 8.6 |
| 02:58 ET | 400 | 8.35 |
| 03:00 ET | 100 | 8.585 |
| 03:07 ET | 100 | 8.375 |
| 03:09 ET | 200 | 8.5 |
| 03:12 ET | 400 | 8.555 |
| 03:14 ET | 100 | 8.4 |
| 03:16 ET | 200 | 8.41 |
| 03:43 ET | 300 | 8.3 |
| 03:56 ET | 200 | 8.295 |
| 03:59 ET | 100 | 8.33 |
Jul 15, 2024
Nyxoah Appoints Scott Holstine as Chief Commercial Officer, from 2:00AM ET on Monday Jul 15, 2024 by Dow Jones
2:00AM ET on Monday Jul 15, 2024 by Dow Jones
Jul 3, 2024
Nyxoah Has Signed a EUR37.5 Million Loan Facility Agreement with the European Investment Bank, from 6:30AM ET on Wednesday Jul 03, 2024 by Dow Jones
6:30AM ET on Wednesday Jul 03, 2024 by Dow Jones
Jul 1, 2024
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA, from 2:00AM ET on Monday Jul 01, 2024 by Dow Jones
2:00AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 28, 2024
Information on the total number of voting rights and shares, from 4:30PM ET on Friday Jun 28, 2024 by Dow Jones
4:30PM ET on Friday Jun 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nyxoah SA | 269.4M | 0.0x | --- |
Company Information
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Contact Information
- Headquarters
- Rue Edouard Belin 12MONT-SAINT-GUIBERT, Belgium 1435
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $269.4M |
|---|---|
Revenue (TTM) | $5.1M |
Shares Outstanding | 34.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-1.51 |
Book Value | $3.42 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 52.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -895.46% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
